Globe Life Inc. (GL) Stock: Price, Forecast & Analyst Target
Globe Life Inc. (GL) — MoonshotScore 75/100 (Strong band), calculated Oct 6, 2026. Price $166.28 (+0.22%), as of the Oct 6, 2026 trading session; market cap $13.0B. Expected results Oct 21, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 28.55× (market value Oct 6, 2026; cash Jun 30, 2026) · expected results Oct 21, 2026
Globe Life Inc. · GL · NYSE · Financial Services · Insurance - Life
Research dated 2026-09-13: Globe Life sells life insurance, supplemental health coverage and annuities to households across the lower-middle and middle-income market, with life insurance providing the larger reported revenue base. Its durability rests on converting premium growth into underwriting profit and cash generation after temporary benefits from assumption updates fade.
Price as of Oct 6, 2026
Key Statistics
MoonshotScore v2 · Globe Life (GL)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and durable growth, though the balance sheet is only decent; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Growing; Momentum: Rising.
- quarterly revenue $1.60B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 2 of 8
- expected results Oct 21, 2026
Helping: business quality, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 74 | Strong | |
| 74 | Strong | |
| 73 | Strong | |
| 73 | Strong | |
| 75 | Strong | |
| 75 | Strong |
The score was 75 in the stored Oct 5, 2026 snapshot and remains 75 in the current publication computed Oct 6, 2026 (0); the largest pillar moves were Momentum +2; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $166.28 | |
| Change on the day | +0.22% | |
| 52-week range | $127.85–$191.55 | |
| Market capitalisation | $13.0B | |
| Price / earnings (trailing) | 10.76 | |
| Shares traded on the day | 644K | |
| Beta (volatility vs the S&P 500) | 0.46 | |
| Dividends per share (last 12 months) | $1.26 | |
| Dividend yield (last 12 months) | 0.75% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For the full year, we expect total premium revenue growth to be in the range of 6.5% to 7%.
Frank Martin Svoboda · Statement from
While we anticipate life underwriting margin to be between 43% to 45% for full year 2026, We do expect it to be over 50% in the third quarter, due to the anticipated impact of assumption updates.
Frank Martin Svoboda · Statement from
Chronological order, not a duration scale. Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsCouncil Score · weighted blend of 2 available disciplines
Council score for Globe Life (GL): Bullish Lean
73/100 · ACouncil is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 6, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 7, 2026, except a card that shows its own read date.
Watch the GL film — every key number, told as a short cinematic story
~2 min · open the film
What is Globe Life (GL), and what does it report?
Short answer · as of
Globe Life is primarily a household protection insurer, not an asset manager that happens to own insurance operations. Customers buy life protection, Medicare supplements, critical-illness and accident coverage, while annuities add a savings-oriented product line.
Research dated 2026-09-13.
Globe Life is primarily a household protection insurer, not an asset manager that happens to own insurance operations. Customers buy life protection, Medicare supplements, critical-illness and accident coverage, while annuities add a savings-oriented product line.
Reported revenue combines insurance operations with the economics of a substantial investment portfolio. Life contributes considerably more segment revenue than health, while underwriting margins reveal how much premium remains after the associated insurance costs.
What do the latest results show for Globe Life (GL)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $1.60B.
Research dated 2026-09-13.
The latest results extended the upward revenue trend and produced higher net income and diluted earnings than the preceding period. Revenue exceeded consensus, yet earnings fell short, showing that premium and investment-related growth did not translate cleanly into the expected bottom line.
Operating cash flow remained positive but retreated from the preceding period. Management separately expects continued premium growth and says assumption updates should lift life underwriting margin temporarily, while health underwriting remains within its stated outlook range.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $1.60B Jun 30, 2026
- Latest quarter · SG&A
- −$174.43M Jun 30, 2026
- Latest quarter · FMP standardized operating result
- −$629.62M Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $1.60B | Not available | −$174.43M | −$629.62M |
| Mar 31, 2026 | $1.56B | Not available | $401.90M | $368.13M |
| Dec 31, 2025 | $1.52B | Not available | $92.00M | $356.26M |
| Sep 30, 2025 | $1.51B | Not available | $0.00 | $477.10M |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $1.60B Jul 22, 2026
- Latest report · revenue estimate
- $1.59B Jul 22, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 22, 2026
- Latest report · EPS vs estimate
- Below estimate Jul 22, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 22, 2026 | $1.60B | $1.59B | $3.6100 | $3.6700 |
| Apr 22, 2026 | $1.56B | $1.56B | $3.4300 | $3.4700 |
| Feb 4, 2026 | $1.52B | $1.53B | $3.3900 | $3.4400 |
| Oct 22, 2025 | $1.51B | $1.52B | $4.8100 | $4.6000 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $1.60B | $288M | $3.65 (diluted) |
| Q1 FY2026 | $1.56B | $271M | $3.45 (diluted) |
| Q4 FY2025 | $1.52B | $266M | $3.29 (diluted) |
| Q3 FY2025 | $1.51B | $388M | $4.71 (diluted) |
What are the financial strengths and risks for Globe Life (GL)?
Short answer
Cash and short-term investments were $455.38M at the Jun 30, 2026 balance-sheet date. Operating cash flow was $314.06M for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Globe Life has generated positive operating cash flow throughout the reported series, generally with modest capital spending. That supports recurring distributions without requiring the company to rely solely on balance-sheet liquidity.
The large investment balance must be read alongside substantial insurance liabilities; it is not equivalent to freely deployable cash. Debt is meaningful, and a recently disclosed credit agreement adds another reason to monitor financing structure, while weaker underwriting or adverse assumption changes could pressure earnings even if premium revenue keeps rising.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 0.98 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $314.06M Jun 30, 2026
- Previous quarter · operating cash flow
- $420.94M Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $314.06M | −$16.49M |
| Mar 31, 2026 | $420.94M | −$24.91M |
| Dec 31, 2025 | $350.60M | −$20.50M |
| Sep 30, 2025 | $305.98M | −$97.29M |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at Globe Life (GL)?
Short answer · as of
The next earnings report is expected on Oct 21, 2026.
Research dated 2026-09-13.
At the scheduled earnings release, compare premium growth with the stated outlook and separate recurring life underwriting performance from the anticipated benefit of assumption updates. Health underwriting margin also deserves attention because the smaller health segment is expected to absorb a developing business that has not yet reached management’s target scale.
Consensus pairs lower sequential revenue with a pronounced earnings step-up. Meeting that combination would require stronger profit conversion, making the relationship among reported revenue, underwriting margins and operating cash flow more informative than the headline earnings comparison alone.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
For the full year, we expect total premium revenue growth to be in the range of 6.5% to 7%.
Frank Martin Svoboda ·
While we anticipate life underwriting margin to be between 43% to 45% for full year 2026, We do expect it to be over 50% in the third quarter, due to the anticipated impact of assumption updates.
Frank Martin Svoboda ·
For the full year, we anticipate health underwriting margins to be between 23% to 27%.
Frank Martin Svoboda ·
For the full year 2026, we expect every sales to be approximately $50 million As a start up, they do not yet have the scale to meet our target margins but we anticipate, as they continue to grow sales, and thus premium, they will ultimately contribute to UA Health margins as they achieve scale and generate a credible block of business.
James Matthew Darden ·
How does Globe Life compare with its peers?
Short answer
Globe Life's score ranks 7th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Globe Life combines a life-led insurance franchise with a sizable supplemental health operation focused on households below the affluent market. That mix differs from a pure life carrier and from a health insurer centered on comprehensive medical benefits: Globe Life’s health products supplement other coverage rather than replace it.
Its investment portfolio is economically central, as with other life insurers, but segment revenue remains concentrated in life and health protection. Comparisons are therefore most useful when they account for product mix, underwriting margins and investment-backed liabilities rather than treating consolidated revenue as directly interchangeable across insurers.
| Company | Price | Market value | Score |
|---|---|---|---|
| $279.13 Oct 6, 2026 | $8.68B | 93 5-pillar Oct 6, 2026 | |
| $270.96 Oct 6, 2026 | $13.4B | 91 5-pillar Oct 6, 2026 | |
| $23.83 Oct 6, 2026 | $4.26B | 88 5-pillar Oct 6, 2026 | |
| $113.54 Oct 6, 2026 | $39.4B | 85 5-pillar Oct 6, 2026 | |
| $97.16 Oct 6, 2026 | $62.5B | 84 5-pillar Oct 6, 2026 | |
| $140.07 Oct 6, 2026 | $11.6B | 82 5-pillar Oct 6, 2026 | |
| Globe Life (GL) — this page | $166.28 | $13.0B | 75 |
| $54.04 Oct 6, 2026 | $5.04B | 72 5-pillar Oct 6, 2026 | |
| $91.83 Oct 6, 2026 | $14.5B | 63 5-pillar Oct 6, 2026 | |
| $8.48 Oct 6, 2026 | $12.8B | 56 5-pillar Oct 6, 2026 | |
| $24.60 Oct 6, 2026 | $30.6B | 47 5-pillar Oct 6, 2026 | |
| $42.08 Oct 6, 2026 | $7.83B | 38 5-pillar Oct 6, 2026 | |
| $9.87 Oct 6, 2026 | $3.51B | 32 5-pillar Oct 6, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $166.00 – $200.00
- Consensus target
- $183.00
- Median target
- $183.00
Consensus record · Captured .
Measured against a quoted price of $166.28 (as of Oct 6, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 22, 2026
- Transactions
- 100
- Identified insiders
- 10
- Purchases
- 0
- Sales
- 48
- Other transactions
- 52
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 83.7% Period end Jun 30, 2026
- Previous quarter · ownership
- 81.8% Prior to period end Jun 30, 2026
- Reporting holders
- 718 Period end Jun 30, 2026
- Previous quarter · holders
- 680 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 5,528,883 |
| Vanguard Capital Management LLC | 5,080,734 |
| Invesco Ltd. | 4,619,219 |
| Vanguard Portfolio Management LLC | 4,181,598 |
| State Street Corp | 3,735,409 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about Globe Life (GL)?
What Investors Ask About Globe Life (GL) — Financial Services
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
Is Globe Life mainly a life insurer or a supplemental health insurer?
Life insurance is the larger reported segment, while supplemental health remains a substantial contributor. Annuities and investments broaden the model but do not change its life-led operating profile.
Why is Globe Life’s investment portfolio so large?
Investment assets are integral to the economics of a life insurer carrying long-duration policy obligations. They should be considered against Globe Life’s insurance liabilities rather than treated as idle corporate cash.
Why can Globe Life revenue beat expectations while earnings miss?
The latest release showed that exact split. Underwriting margins and assumption updates can alter profit conversion independently of the consolidated revenue comparison.
What could lift Globe Life’s life underwriting margin temporarily?
Management expects assumption updates to provide a temporary lift. The more durable signal will be the margin retained after that effect passes while premium revenue continues to develop.
What is the GL stock price today?
The last price recorded on this page for Globe Life Inc. (GL) is $166.28, as of the Oct 6, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the GL price target?
The analyst consensus price target for Globe Life Inc. (GL) is $183.00 (range $166.00 to $200.00, median $183.00), per FMP data captured Oct 5, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
When are GL's next earnings?
The next earnings date listed on this page for Globe Life Inc. (GL) is Oct 21, 2026. Companies sometimes move report dates, so the company's own announcement is the final word on timing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (81 figures)
The 81 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Frank Martin Svoboda (Jul 23, 2026): For the full year, we expect total premium revenue growth to be in the range of 6.5% to 7%. Frank Martin Svoboda (Jul 23, 2026): While we anticipate life underwriting margin to be between 43% to 45% for full year 2026, We do expect it to be over 50% in the third quarter, due to the anticipated impact of assumption updates. Frank Martin Svoboda (Jul 23, 2026): For the full year, we anticipate health underwriting margins to be between 23% to 27%. James Matthew Darden (Jul 23, 2026): For the full year 2026, we expect every sales to be approximately $50 million As a start up, they do not yet have the scale to meet our target margins but we anticipate, as they continue to grow sales, and thus premium, they will ultimately contribute to UA Health margins as they achieve scale and generate a credible block of business. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | Mckinney, TX | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "7677 Henneman Way, McKinney, TX, 75070, US". |
FMP — 69 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $166.28 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-06T20:00:02.000Z. | |
px.change | Change on the day | +0.22% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalization | $13.0B | FMP | Financial Modeling Prep (FMP) quote — Provider market cap uses the share class it prices; a company with more than one class may show a larger total elsewhere. Market cap record date: 2026-10-06. Source capture time was not supplied. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | +$0.36 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $1.60B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.range52 | 52-week range | $127.85–$191.55 | FMP | Financial Modeling Prep (FMP) quote | |
px.pe | Price / earnings (trailing) | 10.76 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 644K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.46 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Frank Martin Svoboda | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 3,695 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $5.12B, net result $1.03B; FY2022 revenue $5.23B, net result $894.39M; FY2023 revenue $5.45B, net result $970.76M; FY2024 revenue $5.78B, net result $1.07B; FY2025 revenue $6.00B, net result $1.16B | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Life Segment $3.36B · Health Segment $1.53B | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 17.0% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $1.60B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | −$174.43M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | −$629.62M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $1.56B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $401.90M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | $368.13M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $1.52B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $92.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | $356.26M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $1.51B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | $477.10M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-07-22.revenue_actual | Revenue · reported — report date 2026-07-22 | $1.60B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-22.revenue_estimated | Revenue · estimate — report date 2026-07-22 | $1.59B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-22.eps_actual | EPS · reported — report date 2026-07-22 | $3.6100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-22.eps_estimated | EPS · estimate — report date 2026-07-22 | $3.6700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-22.revenue_actual | Revenue · reported — report date 2026-04-22 | $1.56B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-22.revenue_estimated | Revenue · estimate — report date 2026-04-22 | $1.56B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-22.eps_actual | EPS · reported — report date 2026-04-22 | $3.4300 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-22.eps_estimated | EPS · estimate — report date 2026-04-22 | $3.4700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-04.revenue_actual | Revenue · reported — report date 2026-02-04 | $1.52B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-04.revenue_estimated | Revenue · estimate — report date 2026-02-04 | $1.53B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-04.eps_actual | EPS · reported — report date 2026-02-04 | $3.3900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-04.eps_estimated | EPS · estimate — report date 2026-02-04 | $3.4400 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-22.revenue_actual | Revenue · reported — report date 2025-10-22 | $1.51B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-22.revenue_estimated | Revenue · estimate — report date 2025-10-22 | $1.52B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-22.eps_actual | EPS · reported — report date 2025-10-22 | $4.8100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-22.eps_estimated | EPS · estimate — report date 2025-10-22 | $4.6000 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $455.38M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $314.06M | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $20.59B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $2.94B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 2.13× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | $314.06M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | $420.94M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-06-30.capex_m | Capital expenditure (reported) — period end 2026-06-30 | −$16.49M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.capex_m | Capital expenditure (reported) — period end 2026-03-31 | −$24.91M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | $350.60M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.capex_m | Capital expenditure (reported) — period end 2025-12-31 | −$20.50M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | $305.98M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.capex_m | Capital expenditure (reported) — period end 2025-09-30 | −$97.29M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $166.00 – $200.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $183.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $183.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 100 transactions · 0 purchases, 48 sales, 52 other transactions · 10 identified insiders · of the newest 100 records, those within the last 180 days, newest dated Sep 22, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.ownership_pct | Institutional ownership | 83.7% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 81.8% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 718 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 680 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Blackrock, INC. — shares in provider snapshot | 5,528,883 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Vanguard Capital Management LLC — shares in provider snapshot | 5,080,734 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Invesco Ltd. — shares in provider snapshot | 4,619,219 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Vanguard Portfolio Management LLC — shares in provider snapshot | 4,181,598 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | State Street Corp — shares in provider snapshot | 3,735,409 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Oct 21, 2026 | UNRECORDED | Stored earnings-calendar observation — Captured 2026-09-30 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 2 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-05 | |
fin.scores | Distress and quality screens | Altman Z 0.98 · Piotroski F 6 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-03 · Expired observation |
COMPUTED — 5 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 28.55× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $455.38M at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-06. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio. |
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $1.26 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-06, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 0.75% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-22.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($1.60B) with the recorded estimate ($1.59B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-22.eps_actual.comparison | Latest report · EPS vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($3.6100) with the recorded estimate ($3.6700) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 75 of 100 · Strong · pillars 77 / 58 / 62 / 79 / 71 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 75 (stored snapshot Oct 5, 2026) → 75 (current publication computed Oct 6, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Earnings-history note. Source series as of 2026-07-22. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-22.revenue_actual,earn.history.depth.2026-07-22.revenue_estimated,earn.history.depth.2026-07-22.revenue_actual.comparison,earn.history.depth.2026-07-22.eps_actual.comparison,earn.history.depth.2026-07-22.eps_actual,earn.history.depth.2026-07-22.eps_estimated,earn.history.depth.2026-04-22.revenue_actual,earn.history.depth.2026-04-22.revenue_estimated,earn.history.depth.2026-04-22.eps_actual,earn.history.depth.2026-04-22.eps_estimated,earn.history.depth.2026-02-04.revenue_actual,earn.history.depth.2026-02-04.revenue_estimated,earn.history.depth.2026-02-04.eps_actual,earn.history.depth.2026-02-04.eps_estimated,earn.history.depth.2025-10-22.revenue_actual,earn.history.depth.2025-10-22.revenue_estimated,earn.history.depth.2025-10-22.eps_actual,earn.history.depth.2025-10-22.eps_estimated. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2026-06-30.capex_m,fin.opcf.depth.2026-03-31.capex_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.capex_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m,fin.opcf.depth.2025-09-30.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Life Segment: $3.36B; Health Segment: $1.53B | 2025-12-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-07-23 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Sector / industry (provider taxonomy) | Financial Services / Insurance - Life The company's SEC filings classify it under SIC 6311 — Life Insurance. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $21.05B; Cash and short-term investments: $455.40M; Long-term investments: $20.59B; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2025-12-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-07-22 | FMP | Financial Modeling Prep (FMP) earnings |
| Cash, investments and debt | Total debt: $2.94B; Liquidity basis: cash and short-term investments; Total liabilities: $25.41B; Cash and short-term investments: $455.38M; Cash and investments: $21.05B; Long-term investments: $20.59B; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Trailing twelve-month ratio set | Quick ratio: 1.41; Current ratio: 1.41; Debt to equity: 0.48; Net margin: 19.6%; Gross margin: 17%; Operating margin: 9.2%; Return on assets: 3.8%; Return on equity: 20.3% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Recent dividends paid | Captured record · 4 entries
Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here. | 2026-07-06 | FMP | Financial Modeling Prep (FMP) dividend history |
| Next scheduled dividend | Ex date: 2026-10-05; Declared on: 2026-08-05; Record date: 2026-10-05; Payment date: 2026-10-30; Amount per share: $0.33 Amount is per share as declared, before any withholding. Owning the share before the ex-date is what carries entitlement. | 2026-08-05 | FMP | Financial Modeling Prep (FMP) dividend calendar |
| Recent SEC filings |
| 2026-08-07 | OFFICIAL | SEC EDGAR filer submissions |
| Next earnings report | Date: 2026-10-28; EPS estimate: $4.89 per share; Revenue estimate: $1.56B The date is our provider's estimate until the company confirms it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-13 | FMP | Financial Modeling Prep (FMP) analyst estimates |
Data provided for informational purposes only.
ETFs that hold GL
Funds in our ETF coverage that list GL among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| Invesco S&P 500 Equal Weight Financials ETF (RSPF) | 1.47% |